PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-03-11

Date Title Company
11-Mar-2026 First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat Gesynta Pharma
11-Mar-2026 Coulter Partners places Dr. David Rosenbaum as Chief Development Officer of Syntis Bio Coulter Partners
11-Mar-2026 Cognito Therapeutics Appoints Thomas Fagan as Executive Vice President, Alzheimer’s Portfolio Businesswire
11-Mar-2026 Catalent and GelMEDIX Enter Global Partnership for the Development and Clinical Manufacturing of iPSC-Derived Cell Therapies in Ocular and Retinal Diseases Businesswire
11-Mar-2026 Orbia Fluor & Energy Materials Accelerates U.S. Regulatory Pathway for its Low-GWP Propellant with Type IV DMF Registration Orbia Fluor & Energy Materials
11-Mar-2026 Neurogene to Participate in Stifel 2026 Virtual CNS Forum Businesswire
11-Mar-2026 Veristat Expands Regulatory and Clinical Services to Chinese Drug and Device Companies Seeking Efficient Way to Enter European Markets Businesswire
11-Mar-2026 NASA Awards Redwire $4 Million In Additional Funding to Support Trailblazing Drug Development in Microgravity Businesswire
11-Mar-2026 AI Maverick Intel Announces Strategic Right of First Refusal Agreement with HEAL Group ACCESS Newswire
11-Mar-2026 Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site Businesswire
11-Mar-2026 Aplantex and Investissement Québec Team up to Produce Molecules for the Cosmetic and Food Industries Businesswire
11-Mar-2026 Brainomix Deploys AI Imaging Platform Across West Virginia University (WVU) Health System Network to Support Stroke Care Brainomix
11-Mar-2026 Cambridge Cognition Investment, Monument Therapeutics, Announces First Patient Dosed in Clinical Trial of MT1988 in Patients at Clinical High Risk for Psychosis Cambridge Cognition Investment
11-Mar-2026 National Health Service to offer VEOZA▼™ (fezolinetant) for the treatment of moderate-to-severe hot flushes and night-sweats associated with menopause when hormone replacement therapy is unsuitable. Astellas
11-Mar-2026 Commit Biologics appoints serial biotech founder as new CEO to take complement-powered immune engagers into the clinic Commit Biologics
11-Mar-2026 Chiesi and Bespak partner to advance Carbon Minimal Inhaler production with UK manufacturing site Bespak
11-Mar-2026 Codethink Opens Early Access to IEC 61508 Mapping for the Eclipse Trustable Software Framework Businesswire
11-Mar-2026 TRNR Completes Acquisition of Ergatta, Confirms Increased 2026 Pro Forma Revenue Guidance of $30m+ ACCESS Newswire
11-Mar-2026 Dr. Sean Doherty Recognized as Boston Magazine Top Doctors(TM) 2026 - Plastic Surgery ACCESS Newswire
11-Mar-2026 Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts ACCESS Newswire